J A Hardin. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultBurkitt Lymphoma/drug therapyCyclophosphamide/administration & dosageCyclophosphamide/therapeutic useFemaleFollow-Up StudiesHematocritHumansInfantInfant, NewbornInjections, IntravenousLeukocyte CountMaleMaternal-Fetal ExchangeOrbital Neoplasms/drug therapyPregnancyPregnancy Complications/drug therapyTime Factors
Substances: See more » Cyclophosphamide
Year: 1972 PMID: 5049899
Source DB: PubMed Journal: Obstet Gynecol ISSN: 0029-7844 Impact factor: 7.661